Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64951 - 64975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	CYP17A1	1586	downregulated	resveratrol analog results in decreased expression of CYP17A1 mRNA	10q24.32	A23917
Resveratrol	Investigational	CYP17A1	1586	downregulated	resveratrol results in decreased expression of CYP17A1 mRNA	10q24.32	A23917 A23918
Resveratrol	Investigational	CYP19A1	1588	upregulated	resveratrol analog results in increased expression of CYP19A1 mRNA	15q21.2	A23917
Resveratrol	Investigational	CYP19A1	1588	downregulated	resveratrol results in decreased expression of CYP19A1 mRNA	15q21.2	A23919 A23920
Resveratrol	Investigational	CYP1A1	1543	downregulated	resveratrol results in decreased expression of CYP1A1 mRNA	15q24.1	A23921 A22289 A23922
Resveratrol	Investigational	CYP1A1	1543	upregulated	resveratrol results in increased expression of CYP1A1 mRNA	15q24.1	A21820 A23923 A21059 A20456 A23853 A21821 A21062
Resveratrol	Investigational	CYP1B1	1545	downregulated	resveratrol results in decreased expression of CYP1B1 mRNA	2p22.2	A23921 A21068 A23923 A23859
Resveratrol	Investigational	CYP21A2	1589	downregulated	resveratrol results in decreased expression of CYP21A2 mRNA	6p21.33	A23918
Resveratrol	Investigational	CYP27A1	1593	upregulated	resveratrol results in increased expression of CYP27A1 mRNA	2q35	A23843
Resveratrol	Investigational	CYP3A4	1576	upregulated	[resveratrol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA	7q22.1	A21086
Resveratrol	Investigational	CYP3A4	1576	upregulated	resveratrol results in increased expression of CYP3A4 mRNA	7q22.1	A21823
Resveratrol	Investigational	CYP4F2	8529	upregulated	resveratrol results in increased expression of CYP4F2 mRNA	19p13.12	A22781
Resveratrol	Investigational	DAPK1	1612	upregulated	resveratrol results in increased expression of DAPK1 mRNA	9q21.33	A23924
Resveratrol	Investigational	DAXX	1616	downregulated	resveratrol results in decreased expression of DAXX mRNA	6p21.32	A22498
Resveratrol	Investigational	DDB2	1643	upregulated	resveratrol results in increased expression of DDB2 mRNA	11p11.2	A23852
Resveratrol	Investigational	DDC	1644	upregulated	resveratrol results in increased expression of DDC mRNA	7p12.2-p12.1	A21310
Resveratrol	Investigational	DDIT3	1649	upregulated	resveratrol results in increased expression of DDIT3 mRNA	12q13.3	A23925
Resveratrol	Investigational	DDR2	4921	downregulated	resveratrol results in decreased expression of DDR2 mRNA	1q23.3	A23854
Resveratrol	Investigational	DEFB4A	1673	upregulated	[resveratrol results in increased activity of SIRT1 protein] which results in increased expression of DEFB4A mRNA	8p23.1	A23916
Resveratrol	Investigational	DEK	7913	downregulated	resveratrol results in decreased expression of DEK mRNA	6p22.3	A22498
Resveratrol	Investigational	DEPTOR	64798	downregulated	resveratrol results in decreased expression of DEPTOR mRNA	8q24.12	A22289
Resveratrol	Investigational	DFFA	1676	downregulated	resveratrol results in decreased expression of DFFA mRNA	1p36.22	A22498
Resveratrol	Investigational	DFFA	1676	upregulated	resveratrol results in increased expression of DFFA mRNA	1p36.22	A23847
Resveratrol	Investigational	DGKA	1606	upregulated	resveratrol results in increased expression of DGKA mRNA	12q13.2	A23852
Resveratrol	Investigational	DHRS3	9249	upregulated	resveratrol results in increased expression of DHRS3 mRNA	1p36.21	A22289

Displaying entries 64951 - 64975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability